Kelvin Kering retweeted
Prof Faith Osier: The Kenyan scientist bringing vaccine manufacturing closer home #HealthyNation
zurl.co/2Ay0e
Kelvin Kering retweeted
Antibiotic resistance means one day
a simple cut could kill like it did 100 years ago.
Kelvin Kering retweeted
A new study found that #typhoid continues to affect millions in #India, with rising #DrugResistance making the disease more dangerous and harder to treat.
Read more in @TheLancet Regional Health: thelancet.com/journals/lanse…
#TakeOnTyphoid #AMR
Kelvin Kering retweeted
A fully funded PhD studentship is now open.
Join a global research team to tackle neonatal sepsis and antimicrobial resistance in Kenyan maternity wards using genomics, microbiome science, and machine learning.
Deadline: January 15, 2026
Apply now: shorturl.at/8qNja
Kelvin Kering retweeted
Join us @UniofOxford! Shoot your shot!
Projects link: ndorms.ox.ac.uk/study/kenned…
To be a bit biased, my brilliant supervisor @yluo86 has an amazing project listed. What are you waiting for?
Kelvin Kering retweeted
📢 #Kenya is introducing #typhoid conjugate vaccines (TCVs), launching a milestone campaign to protect 21M children from typhoid. Congratulations to the leaders in Kenya and the partners who made it happen!
@WHOAFRO @Gavi @PATHtweets @UNICEFKenya @MOH_Kenya
Kelvin Kering retweeted
🌍A new study, led by the #MAAP research consortium, covering 14 African countries from 2016-2019, published @PLOSMedicine, finds resistance to critical antibiotics used to treat severe bacterial infections is widespread and has significant variations.
flemingfund.org/publications…
Kelvin Kering retweeted
🆕 Researchers at @Cornell identified an antibiotic, rifampin, that is 99.9% effective against Salmonella Typhi, the bacterium that causes #typhoid.
The likelihood of encountering rifampin-resistant typhoid cases is less than 1 in every 1,000 cases, according to the findings.
Read more: news.cornell.edu/stories/202…
#TakeOnTyphoid
Kelvin Kering retweeted
🚨 This is Big!
New GARDP research shows that people with multidrug-resistant infections in LMICs are not receiving the appropriate antibiotics because of large gaps in access. Improving access and developing new antibiotics must be a priority,
📖 Read the study 👇
thelancet.com/journals/lanin…
Kelvin Kering retweeted
Are you interested in a MSc in Bioinformatics of Infectious Diseases and Pathogen Genomics? This opportunity at Stellenbosch University is highly recommended— apply now if you’re interested.
Deadline: 26 June 2025
More details below ⬇️
Kelvin Kering retweeted
This opportunity is for early-career researchers eager to develop their own groundbreaking contributions to human life, health, and wellbeing. It was shared on the Afredac Ubuntu Platform 4 days ago!
Visit afredac.net to read more and check other opportunities!
Kelvin Kering retweeted
The #GlobalAISummit2025 in Kigali was eye-opening!
Powerful insights on AI’s role across sectors, need for infrastructure & access, and ethical use to prevent widening inequalities.
Loved the idea: AI = African Intelligence
As H.E. @PaulKagame said, Africa must lead, not follow!
Kelvin Kering retweeted
A new Gram-negative antibiotic from a novel chemical class! Gepotidacin is a triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by interaction with DNA gyrase and topoisomerase IV (similar target as quinolones, but different site).
fiercepharma.com/pharma/gsk-…
Kelvin Kering retweeted
OPEN for Applications! African STARS Fellowship program - Spend 4 months with us at CERI or IPD to receive advanced training in genomics, diagnostics, and/or vaccine development. Unique opportunity to early-career scientist born in or based in Africa - starsfellows.africa
Happy to join colleagues from East Africa during the second workshop of the 2nd COHORT of Young East Africa Research Scientists (YEARS) Forum.
Kelvin Kering retweeted
Pls share: Postdoc position in microbiology with a focus on antibiotic heteroresistance
Kelvin Kering retweeted
We're inviting applications from researchers across Africa working in Antimicrobial Resistance (AMR), surveillance, or epidemiology and Individuals with basic knowledge in Molecular Biology for our upcoming hands-on training on AMR, Bacterial Genomics & Bioinformatics scheduled for January 2025.
Learn more and apply at bit.ly/4iFe9zf
#AMR #Bioinformatics #Training
#Research #Africa
Kelvin Kering retweeted
Investigators report broad dissemination of a highly drug-resistant Vibrio cholerae O1 El Tor strain across Africa. Read the full correspondence: nej.md/3Zxfwaf
Kelvin Kering retweeted
We are opening a call for applications 2025 – Creation of new junior research groups at the Institut Pasteur in Paris @institutpasteur All details on our web site : research.pasteur.fr/en/call/…




































